320 Bent Street
About Moderna, Inc.
At Moderna, we are pioneering the development of a new class of drugs made of messenger RNA (mRNA). This novel drug platform builds on the discovery that modified mRNA can direct the body’s cellular machinery to produce nearly any protein of interest, from native proteins to antibodies and other entirely novel protein constructs that can have therapeutic activity inside and outside of cells.
We have a clear mission to propel the field of mRNA science forward and deliver new medicines to patients and a unique vision for how to achieve this mission.
Our Mission: Deliver on the promise of mRNA science to create a new generation of transformative medicines for patients.
Our Vision: Unlock the potential of mRNA Therapeutics™ by establishing an ecosystem of teams and partners that will work together to develop the broadest possible array of drugs, across diverse therapeutic areas and routes of administration, for serious diseases that are not treatable today.
147 articles with Moderna, Inc.
Moderna Therapeutics Grabs $25 Million Defense Advanced Research Projects Agency Grant to Develop Messenger RNA Therapeutics
Study Published in Nature Biotechnology Demonstrates Ability of Moderna Therapeutics's Novel Therapeutic Paradigm to Repair and Regenerate Damaged Heart Tissue
Biotech Industry Veteran Joseph Bolen Joins Moderna Therapeutics to be President of Research and Development